Abstract
The climacteric, marked by the transition from the reproductive to the non-reproductive phase in a woman's life, is a period that presents significant challenges in terms of urogynecological health. Disorders in this sphere during the climacteric can affect women's quality of life, requiring an in-depth understanding of the underlying mechanisms and management strategies. This integrative review seeks to critically explore the existing literature on the relationship between climacteric and urogynecological disorders, providing a comprehensive analysis of these topics. The search for articles was carried out in relevant databases, using specific descriptors such as menopause, climacteric, urogynecological disorders, among others. Studies addressing hormonal effects, clinical manifestations and therapeutic options during the climacteric period were selected. The references used in this review were selected based on their relevance to the topic, as indicated in the references section. Analysis of the studies reveals a complex interconnection between the climacteric and urogynecological disorders. Evidence highlights hormonal changes as contributing factors to symptoms such as urinary incontinence, vaginal atrophy and pelvic floor disorders. Different therapeutic approaches, from hormonal interventions to non-hormonal treatments, have been explored in the management of these disorders. This integrative review offers a comprehensive synthesis of the relationship between climacteric and urogynecological disorders. While the evidence highlights the influence of hormonal factors, the complexity of these interactions suggests the need for multidisciplinary approaches in clinical management. A thorough understanding of these relationships is crucial to guide personalized interventions and improve the quality of life of women during the climacteric. However, we identified gaps in knowledge that highlight the need for future research to better delineate these interactions and develop more effective therapeutic strategies.
References
Bulchandani S, Toozs-Hobson P. Urogynecological effects of menopause. Expert Rev Endocrinol Metab. 2014 Jan;9(1):73-77. doi: 10.1586/17446651.2014.866893. Epub 2013 Dec 13. PMID: 30743740.
Calleja-Agius J, Brincat MP. The urogenital system and the menopause. Climacteric. 2015;18 Suppl 1:18-22. doi: 10.3109/13697137.2015.1078206. PMID: 26366796.
Singh S, van Herwijnen I, Phillips C. The management of lower urogenital changes in the menopause. Menopause Int. 2013 Jun;19(2):77-81. doi: 10.1177/1754045313481536. PMID: 23778562.
Legendre G, Ringa V, Fauconnier A, Fritel X. Menopause, hormone treatment and urinary incontinence at midlife. Maturitas. 2013 Jan;74(1):26-30. doi: 10.1016/j.maturitas.2012.10.005. Epub 2012 Nov 8. PMID: 23141079.
Görgen S, Erdogan A, Nossol S, Hamarat M, Tölg C. Effects of age, body mass index, and parity on pelvic floor muscle strength and endurance. Acta Obstet Gynecol Scand. 2015 Jan;94(1):76-82. doi: 10.1111/aogs.12557. PMID: 25230910.
Chalkidou A, Oikonomou E, Lambrinos D, Bothou A, Kyriakou D, Nikolettos K, Marinos G, Iatrakis G, Zervoudis S, Nikolettos N, Tsikouras P. The Comparative Study of the Administration of the Combination Preparation of Isoflavones and Hyaluronic Acid in Menopausal Women for the Treatment of the Symptoms of Menopause, Urogenital Atrophy and Oteoporosis in Relation to Existing Hormone Replacement Therapies. Mater Sociomed. 2023 Sep;35(3):206-214. doi: 10.5455/msm.2023.35.206-214. PMID: 37795159; PMCID: PMC10545921.
Mitchell ES, Woods NF. Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Climacteric. 2013 Dec;16(6):653-62. doi: 10.3109/13697137.2013.777038. Epub 2013 Apr 7. PMID: 23560943.
Woods NF, Mitchell ES. Consequences of incontinence for women during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2013 Sep;20(9):915-21. doi: 10.1097/GME.0b013e318284481a. PMID: 23531687; PMCID: PMC9668244.
Tähtinen RM, Auvinen A, Cartwright R, Johnson TM 2nd, Tammela TL, Tikkinen KA.
Incidences of benign urological diseases and long-term effects of bladder pain syndrome/interstitial cystitis (BPS/IC) on health-related quality of life. BJU Int. 2013 Mar;111(3):484-91. doi: 10.1111/j.1464-410X.2012.11255.x. PMID: 23432834.
Alperin M, Burnett L, Lukacz E, Brubaker L. The mysteries of menopause and urogynecologic health: clinical and scientific gaps. Menopause. 2019 Jan;26(1):103-111. doi: 10.1097/GME.0000000000001209. PMID: 30300297; PMCID: PMC6376984.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Matheus Caldeira ferraz borges, Tiago da Silva Hotta, Bianca Sollitto Siqueira e Silva, Nesrin Khaled Yassine, Marina Righi Bacchin, Júlia Lagoa Pedroni, Ítalo Tufani Alessandri, Henrique Sales Fernandes do Carmo, Giulia Rezende Nóbrega Zamboni, Enzo Mariano Busano, Breno Pimentel Sampaio, Beatriz Borges Credi, Beatriz Bento Gaia da Silva, Luiz Felipe Menezes Thomaz, Lorena Gradella de Arruda Camargo, Flavia Drozdz, Giovanna Teles Dornel, Marinna Verrone Muniz dos Santos, Lucas Machado de Almeida, Maria Fernanda Bernardes Augusto